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HIV-1 LTRKruppel-associated box-containing zinc ﬁnger (KRAB-ZNF) genes constitute the single largest gene
family of transcriptional repressors in the genomes of higher organisms. In this study, we isolated
52 cDNA clones of KRAB-ZFPs from U1 cell lines and screened them to identify which were capable
of regulating HIV-1 gene expression. We identiﬁed 5 KRAB-ZFPs that suppressedP50% of HIV-1 LTR.
Of the 5 identiﬁed KRAB-ZFPs, the expression of ZNF10 signiﬁcantly enhanced the transcriptional
repression activity of the LTR compared with other ZNFs. In addition, the depletion of endogenous
ZNF10 led to the activation of HIV-1 LTR. The repressor activity of ZNF10 was required for TRIM28,
SETDB1 and HP1-gamma binding. These results indicate that ZNF10 could be involved in a potent
intrinsic antiretroviral defense.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The cellular tropism of HIV-1 replication has recently been
found to be controlled by the 50 LTR of HIV-1 [1]. The HIV-1 LTR
functions as a typical promoter, containing several different bind-
ing sites speciﬁc for cellular and viral regulatory proteins [2,3]. It is
regulated not only by viral proteins (Tat, Nef, Vpu) but also by
ubiquitously expressed host factors such as Sp1 and TFIID.
Additionally, inducible transcription factors such as NF-jB, AP1,
Sp1, NFAT, USF, and COUP play roles in LTR-driven gene expres-
sion. These inducible regulatory factors vary in response to stimuli
such as hyperthermia, oxidative stress and infection [4–6].
Moreover, the Kruppel-associated box (KRAB) zinc ﬁnger proteins
(ZNFs) have the potential to regulate HIV-1 gene expression.Several groups have reported that artiﬁcially engineered KRAB
domain-containing zinc ﬁnger proteins that bind to HIV-1
sequences also induce proviral silencing [7–9]. Furthermore, host
proteins such as OTK18 suppress HIV-1 Tat-induced LTR activation
through the negative regulatory element (NRE) and ETS binding
site (EBS). All of these LTR binding elements are important due to
their therapeutic potential in the reactivation of HIV-1 in latently
infected cells [10–12].
Reynolds et al. reported that a genetically engineered KRAB
domain containing a C2H2-type zinc ﬁnger motif suppressed
Tat-mediated HIV-1 LTR activity, thereby making it an attractive
candidate for antiretroviral therapy [8]. In addition, endogenous
OTK18, which contains 13 C2H2-type zinc ﬁnger motifs, inhibits
HIV-1 replication. OTK18 was identiﬁed by differential display of
mRNA fromHIV-1-infectedmacrophages andwas shown to interact
with and suppress the NRE (255/238) and EBS (150/139) in
the HIV-1 LTR [11,13]. More recently, we showed that ZNF350
(ZBRK1) is able to repress HIV-1 replication through binding the
145 to126 region of the HIV-1 LTR and ZNF1 in conjunctionwith
TRIM28 and HDAC2, thereby suppressing HIV-1 LTR-driven gene
expression [14]. Interestingly, the methylation driven by SETDB1
did not inﬂuence this mechanism, which probably reﬂects the fact
that each ZNF has a unique pattern of inhibition. TRIM28 (tripartite
2020 H. Nishitsuji et al. / FEBS Letters 589 (2015) 2019–2025motif-containing protein 28, also known as KRAB-associated
protein 1, KAP1) is a well-characterized transcriptional repressor.
The inhibitionmediated by TRIM28was proven to suppress endoge-
nous retroviruses by recruiting the H3K9 methyltransferase ESET
(also called SETDB1 or KMT1E) and heterochromatin protein 1
(HP1) in mouse ES cells [15,16]. TRIM28-mediated gene-speciﬁc
transcriptional repression requires a ZNF protein such as ZFP809
to directly recognize integrated viral DNA [17]. Furthermore,
TRIM28 inhibits HIV-1 integration through a cellular pathway
targeting acetylated IN [18].
In this study, we investigated the role of KRAB-zinc ﬁnger pro-
teins in the transcriptional repression of HIV-1. We found that
ZNF10 highly represses HIV LTR-mediated transcription compared
with other ZNFs. We also show that ZNF10 in conjunction with
TRIM28, SETDB1 and HP1-gamma suppresses HIV-1 LTR-mediated
transcription.
2. Materials and methods
2.1. Plasmids
The details of the plasmid constructs used in this study are pro-
vided in the Supplementary Materials and Methods section.
2.2. Cells
293T cells were maintained in Dulbecco’s modiﬁed Eagle’s med-
ium supplemented with 10% FBS, 100 units/ml penicillin, and
100 lg/ml streptomycin. MT4 and U1 cells were grown in RPMI
1640 supplemented with L-glutamine (Sigma Aldrich, St. Louis,
MO, USA), 10% fetal bovine serum (FBS) (Biosera, Nuaille, France)
and 1% antibiotics (Sigma Aldrich). The cultures were maintained
at 37 C/5% CO2. On day 4, the U1 cells were collected and cen-
trifuged at 1000 rpm for 3 min. The supernatant was discarded,
and RNA was extracted from the pellets using RNeasy Plus Mini
kits (Qiagen, Venlo, Netherlans). The RNA concentrations were
measured with a spectrophotometer (Thermo Scientiﬁc,
Wilmington, MA, USA), and RNA quality (absence of RNA degrada-
tion) was assessed by gel electrophoresis. The levels of HIV-1 p24
antigen were determined using chemiluminescence enzyme
immunoassays (CLEIAs) (Lumipulsef, FUJIREBIO, Tokyo, Japan).
2.3. Western blotting
The details of the western blotting analysis are provided in the
Supplementary Materials and Methods section.
2.4. Small interfering RNA (siRNA)
KRAB-ZNF (ZNF10, ZNF566, ZNF333, ZNF561, and ZNF324)
mRNA was analyzed, and speciﬁc Stealth RNAi™ predesigned
siRNAs were ordered (Life Technologies, Gland Island, NY, USA).
siTRIM28 and siSETDB1 were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), and siHP1-gamma was pur-
chased from Sigma–Aldrich.
2.5. Immunoprecipitation
293T cells were transfected with 0.5 lg of pHA-ZNF10 using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). At 48 h
post-transfection, the transfected cells were harvested and sus-
pended in 0.5 ml lysis buffer (20 mM Tris–HCl pH 7.5, 250 mM
NaCl, 1 mM EDTA, 5% glycerol, 1% TritonX-100). The cell lysates
were centrifuged at 15000g for 20 min at 4 C, after which thesupernatant was incubated with 1 lg of anti-TRIM28 antibody
and 40 ll of protein G magnetic beads for 2 h at 4 C. The beads
were then washed with PBS containing 0.02% TritonX-100, and
the immunocomplexes were eluted by boiling in 20 ll of 5 sam-
ple buffer and analyzed by SDS–PAGE and Western blotting.
2.6. Luciferase assay
The luciferase assay details are provided in the Supplementary
Materials and Methods section.
2.7. Measurement of HIV-1 p24 antigen
The p24 antigen measurement details are provided in the
Supplementary Materials and Methods section.
2.8. HIV-1 challenge and culture assay
The HIV-1 challenge and culture assay details are provided in
the Supplementary Materials and Methods section.
3. Results and discussion
3.1. Screening results
We obtained the coding DNA sequences (CDSs) of 134 human
ZNFs and queried the NCBI protein database. We then isolated
134 cDNAs encoding Kruppel-related zinc ﬁnger genes from a cell
line latently infected with HIV-1 (U1). To evaluate the level of
expression of the 134 ZNFs in U1 cells, we performed RT-PCR anal-
ysis. We observed no detectable mRNAs encoding 82 of the 134
ZNFs in U1 cells (data not shown). Therefore, we focused on the
other 52 ZNFs as candidate transcriptional repressors of the
HIV-1 LTR.
Next, we determined whether these 52 ZNFs could inhibit
HIV-1 LTR promoter activity. 293T cells were co-transfected with
the KRAB-ZNF expression vectors and with the HIV-1 LTR-driven
luciferase reporter plasmid. As shown in Fig. 1, ZNF10, ZNF566,
ZNF333, ZNF561, and ZNF324 signiﬁcantly suppressed P50%
HIV-1 LTR activity compared with the empty vector control. By
contrast, ZNF416, ZNF115, and ZNF41 potentially acted as positive
regulators of HIV-1, promoting LTR-driven transcription (Fig. 1).
Mysliwice et al. reported that ZFP496 functions as a transcriptional
activator when it is tethered to DNA or when it is directly bound to
the DNA-binding motif [19]. However, in this study we did not
analyze the up-regulation of LTR-driven transcription. To further
investigate the effect of KRAB-ZNF (ZNF10, ZNF566, ZNF333,
ZNF561, and ZNF324)-mediated repression of the LTR, we used
siRNAs speciﬁc for the ﬁve identiﬁed KRAB-ZNFs. The introduction
of each speciﬁc siRNA induced efﬁcient knockdown of expression
of the corresponding protein (Fig. 2A). Knockdown of ZNF10
expression signiﬁcantly enhanced the transcriptional activity of
the LTR compared with the knockdown of other KRAB-ZNFs
(Fig. 2B). The KRAB zinc ﬁnger protein 10 (ZNF10) contains two
KRAB domains (A and B boxes) and nine zinc ﬁnger regions [20].
To evaluate the effect of ZNF10 in T cells, MT-4 cells were trans-
duced with the control or ZNF10-speciﬁc short hairpin RNA
(shRNA) vectors and then infected with HIV-1. Virus replication
was then monitored by measuring the production of p24 in the
supernatant every two days post-infection. The depletion of
ZNF10 in MT-4 cells resulted in twofold more HIV-1 replication
at four and six days post-infection (Fig. 2C). These results suggest
that ZNF10 inhibits HIV-1 gene expression through transcriptional
repression of the LTR.
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Fig. 2. (A) The knockdown of ZNF expression enhances the transcriptional activity of the HIV-1 LTR. 293T cells were treated with 70 nM of the indicated siRNA or control
siRNA for 24 h prior to transfection with 5 ng of pLTR-Luc and 1 ng of pCMV-Renilla-Luc. At 48 h post-transfection, the protein lysates were subjected to SDS–PAGE and
probed for the indicated protein. (B) The luciferase activity of the protein lysates in Fig. 2A was analyzed. Fireﬂy luciferase activity was normalized to Renilla luciferase
activity. (C) The effect of ZNF10 in T cells. MT-4 cells were infected with a lentiviral vector expressing shControl or shZNF10. At 5 days post-infection, the cells were infected
with 2 ng of NL4–3 p24. Virus replication was monitored every 2 days after infection by measuring the amount of p24 viral antigen in the culture supernatant. The results are
representative of three independent experiments, and the error bars show the standard deviations from the mean values.
Fig. 1. The inhibitory effects of HIV-1 LTR-driven transcription by 52 ZNFs. 293T cells (4  105 cells) were transfected with 1 ng of pLTR-luc, 1 ng of pCMV-Renilla and 200 ng
of pHA-ZNFs or p-HA (empty vector) using Lipofectamine 2000 (Invitrogen). At 48 h post-transfection, the levels of luciferase gene expression were determined by measuring
the luciferase activity. Fireﬂy luciferase activity was normalized to Renilla luciferase activity. The results are representative of three independent experiments, and the error
bars show the standard deviations from the mean values.
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LTR
To determine the LTR sequence responsible for the suppressive
function of ZNF10, we generated deletion mutants of the LTR
(Fig. 3A) [14]. The expression of ZNF10 repressed transcription
from the 335 to +282 (Fig. 3C), 245 to +282 (Fig. 3D), and
106 to +282 LTR segments (Fig. 3E), as well as from the
full-length LTR (Fig. 3B). These deletion mutants of the negative
regulatory element (NRE) of HIV-1 LTR did not inﬂuence the sup-
pressive effect of ZNF10. In addition, HIV-1 Tat was not required
for the repressive activity of ZNF10 (Fig. 3H).
A previous study has shown that transcriptional silencing of the
HIV-1 LTR by HP1-gamma requires Sp1, P-TEFb (which leads to thephosphorylation of the RNA polymerase IICTD by recruiting HIV-1
Tat to the TAR) and PCAF (which is known to possess histone acetyl
transferase activity) [21]. To further determine the role of the
cis-elements of the LTR in ZNF10 repression, we introduced muta-
tions into the NF-jB or Sp1 binding sites in the LTR (Fig. 3A). There
was no signiﬁcant suppressive effect of ZNF10 upon mutations of
the NF-jB- or Sp1-binding sites of the LTR (Fig. 3F and G). To deter-
mine the inﬂuence of ZNF10 andof theNF-jB- and Sp1-binding sites
on HIV-1 LTR repression, 293T cells were transfected with
pcDNA-HA or pcDNA-HA-ZNF10, pLTR-luc, pCMV-Renilla-luc, and
pNF-jB-luc or pSp1-luc using Lipofectamine 2000 (Fig. 3I and J).
Furthermore, we examined the over-expression of pNF-jB or pSp1
in HIV-1 LTR-Luc and ZNF10-expressing plasmid-transfected cells
(Fig. 3K and L). The luciferase reporter assays showed that the
Fig. 3. The region of ZNF10 that is responsible for the transcriptional repression of the HIV-1 LTR. (A) Schematic representation of the HIV-1 LTR-driven expression of ﬁreﬂy
luciferase. The numbers shown are relative to the transcriptional start site nucleotide, +1. (B–G) 293T cells transfected with 1 ng of pCMV-Renilla-Luc and 200 ng of pHA or
pHA-ZNF10, along with 5 ng of pLTR-Luc (B) or its corresponding mutants (C–G). The luciferase assay was performed as described in Fig. 1. (H) 293T cells were transfected
with 1 ng of pCMV-Renilla-Luc, 5 ng of pLTR-Luc and 100 ng of pCMV-Tat, along with 200 ng of pHA or pHA-ZNF10. The luciferase assay was performed as described in Fig. 1.
(I, J) 293T cells were transfected with 200 ng of pHA or pHA-ZNF10, 1 ng of pCMV-Renilla-luc and 10 ng of pNF-jB-luc (Agilent Technologies) or 10 ng of pSp1-luc (Qiagen)
using Lipofectamine 2000. The luciferase assay was performed as described in Fig. 1. (K, L) 293T cells were transfected with 200 ng of pHA or pHA-ZNF10, 1 ng of pLTR-luc,
1 ng of pCMV-Renilla-luc and 200 ng of pcDNA-65(NF-jB) or 200 ng of pCIneo-Sp-1 using Lipofectamine 2000. The luciferase assay was performed as described in Fig. 1. The
results are representative of three independent experiments, and the error bars show the standard deviations from the mean values.
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ZNF10 (Fig. 3I–L). These results suggest that the NF-jB and Sp1 sites
within the LTR contain essential elements for the transcriptional
repression of the LTR by ZNF10.To address the binding of ZNF10 to the LTR, we performed an
electrophoretic mobility shift assay (EMSA). Incubation of the
LTR probe containing NF-jB and Sp1 binding sites with nuclear
extract revealed a shifted band (Fig. S1). The LTR-ZNF10 complex
Fig. 4. TRIM28, HP1-gamma and SETDB1 are required for the repressive activity of ZNF10. (A–D) 293T cells were treated with 70 nM of the indicated siRNA for 24 h prior to
transfection with 5 ng of pLTR-Luc, 1 ng of pCMV-Renilla-Luc and 300 ng of pHA or pHA-ZNF10. At 48 h post-transfection, the protein lysates were subjected to SDS–PAGE
and probed for the indicated protein. The luciferase activity of the protein lysates was also analyzed. Fireﬂy luciferase activity was normalized to Renilla luciferase activity. (E)
293T cells were transfected with 500 ng of pHA-ZNF10. At 48 h post-transfection, the cell lysates were immunoprecipitated using an anti-HA antibody, followed by Western
blotting with an anti-TRIM28 antibody. The results are representative of three independent experiments, and the error bars show the standard deviations from the means. (F)
ZNF10 repression is reversed by HDAC inhibitors. 293T-LTR-Luc cells were transfected with 400 ng of pHA or pHA-ZNF10. At 24 h after transfection, the cells were treated
with TSA for 24 h. The levels of luciferase gene expression were determined by measuring the luciferase activity. (G) U1 cells were treated with 5 ng/ml of PMA (Sigma
Aldrich). After 48 h and 72 h, virus replication was monitored by measuring the amount of p24 viral antigen in the culture supernatant. The results are representative of three
independent experiments, and the error bars show the standard deviation from the mean values. The protein lysates were subjected to SDS–PAGE and probed for the
indicated protein.
H. Nishitsuji et al. / FEBS Letters 589 (2015) 2019–2025 2023
2024 H. Nishitsuji et al. / FEBS Letters 589 (2015) 2019–2025was observed to be supershifted by an anti-ZNF10 antibody. To fur-
ther conﬁrm this observation, a supershift was also performed
using nuclear extracts from 293T cells expressing HA-ZNF10 and
an anti-HA antibody. These results indicate that ZNF10 binds to
the NF-jB and Sp1 binding sites of LTR.3.3. Transcriptional repression of the HIV-1 LTR by ZNF10 requires
TRIM28, HP1-gamma and SETDB1
Although the TRIM28/ZNF complex has been observed in the
presence of different ZNFs [22–24], the role of other molecules in
LTR-mediated transcriptional inhibition has been intensively stud-
ied. TRIM28 mediates gene silencing by recruiting the NuRD his-
tone deacetylase (HDAC) complex, the SETDB1 histone
methyltransferase and the heterochromatin-associated protein
HP1-gamma to target promoters [25–29]. In a previous study, we
demonstrated that ZBRK1 in conjunction with TRIM28 and
HDAC2 suppresses HIV-1 LTR-driven gene expression [14]. To
investigate the mechanism involved in ZNF10-mediated repression
of the LTR, we transfected siRNAs speciﬁc for TRIM28, HP1-gamma
or SETDB1 into empty plasmid-transfected or ZNF10-expressing
plasmid-transfected cells. The introduction of each speciﬁc siRNA
knocked down the expression of the corresponding protein
(Fig. 4A–D). The expression of ZNF10 in siControl-transduced cells
repressed LTR-driven transcription (Fig. 4A). By contrast, no
repressive activity of ZNF10 was observed in the siTRIM28,
siHP1-gamma, or siSETDB1-transduced cells (Fig. 4B–D). Further-
more, HA-ZNF10 was found to interact with endogenous TRIM28
(Fig. 4E). These results indicate that TRIM28, HP1-gamma and
SETDB1 play essential roles in the repressive function of ZNF10.
As previously described, TRIM28 interacts with Mi-2alpha and
other components of the NuRD complex. Additionally,
TRIM28-mediated silencing requires both its association with
NuRD and HDAC activity. To test whether histone deacetylases
play a role in the repression of LTR activity by ZNF10 in
293T-LTR-Luc cells, we used the pan-HDAC inhibitor trichostatin
A (TSA). Treatment with 80 nM TSA signiﬁcantly reversed the
ZNF10-mediated repression of LTR-driven transcription in
293T-LTR-Luc cells (Fig. 4F). These results indicate that the
ZNF10-mediated suppression of LTR activity requires HDAC activ-
ity. To investigate whether KFZ10 is inﬂuenced by HIV-1 latency,
the effect of HIV-1 latency was examined in chronically infected
promonocytic (U1) cells. After PMA treatment, the p24 antigen
level was increased and the ZNF10 expression level was reduced
in both cell lines (Fig. 4G). Protein degradation in cells is mediated
by several protease systems. To investigate whether the ZNF10
reduction was due to proteasomal degradation, we treated PMA
stimulated U1 cells with the proteasome inhibitor MG132 to pre-
vent the virus-induced degradation of ZNF10. Our results indicated
that ZNF10 expression was restored by proteasome inhibitors
(Fig. S2). Proteasome inhibitors substantially prevented the degra-
dation of ZNF10 in PMA stimulated U1 cells. Therefore, ZNF10
plays a prominent role in controlling the establishment and main-
tenance of latent HIV-1 provirus in unstimulated cells.
In conclusion, we show that ZNF10 represses HIV LTR-mediated
transcription to a greater extent than other ZNFs.We also show that
ZNF10 in conjunction with TRIM28, SETDB1, and HP1-gamma sup-
presses HIV-1 LTR-mediated transcription. These results suggest
that ZNF10 suppresses HIV-1 LTR-driven gene expression and
may have potential as a novel antiviral therapeutic.Conﬂicts of interest
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